In a meta-analysis this protective effect of H. pylori was restricted to CagA-positive strains, with no significant difference in the risk of IBD between H. pylori CagA seronegative strains, and H. pylori non-exposed individuals (19). Here, S100A8 is linked to inflammatory bowel disease.